Identification of colon cancer subtypes based on multi-omics data—construction of methylation markers for immunotherapy
BackgroundBeing the most widely used biomarker for immunotherapy, the microsatellite status has limitations in identifying all patients who benefit in clinical practice. It is essential to identify additional biomarkers to guide immunotherapy. Aberrant DNA methylation is consistently associated with...
Main Authors: | Benjie Xu, Jie Lian, Xiangyi Pang, Yue Gu, Jiahao Zhu, Yan Zhang, Haibo Lu |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2024-01-01
|
Series: | Frontiers in Oncology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fonc.2024.1335670/full |
Similar Items
-
DNA methylation regulator-mediated modification pattern defines tumor microenvironment immune infiltration landscape in colon cancer
by: Shijin Yuan, et al.
Published: (2022-10-01) -
Prognostic DNA methylation markers for sporadic colorectal cancer: a systematic review
by: Muriel X. G. Draht, et al.
Published: (2018-03-01) -
CHK Methylation Is Elevated in Colon Cancer Cells and Contributes to the Oncogenic Properties
by: Shudong Zhu, et al.
Published: (2021-06-01) -
DNA Methylation Modification Map to Predict Tumor Molecular Subtypes and Efficacy of Immunotherapy in Bladder Cancer
by: Fangdie Ye, et al.
Published: (2021-12-01) -
Correlation of <it>MLH1</it> and <it>MGMT</it> expression and promoter methylation with genomic instability in patients with thyroid carcinoma
by: Santos Juliana Carvalho, et al.
Published: (2013-02-01)